Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
BioWorld - Tuesday, August 4, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home Viking Therapeutics presents GLP-1 and GDIR dual agonists To read the full story, subscribe or sign in
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study
Biological and conformational study of beta-substituted prolines in MT-II template: [PMID: 15009533] Laboratory literature summary: Biological and conformational study of beta-substituted prolines in MT-II template: steric effects leading to research subjects MC5
Rescue of a Drosophila NF1 mutant phenotype by protein kinase A
Liu H, Dear AE, Knudsen LB, Simpson RW: A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
